Literature DB >> 26163884

Apelin attenuates postburn sepsis via a phosphatidylinositol 3-kinase/protein kinase B dependent mechanism: A randomized animal study.

Keqin Luo1, Huibao Long2, Bincan Xu3, Yanling Luo4.   

Abstract

INTRODUCTION: This study aims to investigate whether apelin would regulate inflammatory response and promote survival in an experimental burn sepsis model through a phosphatidylinositol 3-kinase/protein kinase B dependent pathway.
METHODS: Male BALB/c mice were divided into the following groups: sham, burn, burn sepsis, burn sepsis treated with apelin, burn sepsis treated with apelin plus LY294002, and burn sepsis treated with LY294002 alone. Apelin level and inflammatory cytokines in serum were detected by enzyme-linked immuno sorbent assay. Apelin/APJ (apelin receptor, gene symbol APLNR) mRNA expression in spleen and adhesion molecules levels in lung was detected by real-time polymerase chain reaction. Neutrophil infiltration in lung was determined by myeloperoxidase assay. Phosphorylation of protein kinase B in lung was determined by western blot. Mortality rate was monitored.
RESULTS: Burn sepsis induced decreased apelin/APJ mRNA expression in spleen and reduced apelin level in plasma, which were both restored by exogenous apelin treatment. Burn sepsis treated with apelin resulted in decreased interleukin-6, tumor-necrosis factor-alpha, interleukin -1β and monocyte chemotactic protein-1 levels in plasma. Mice with apelin treatment also showed decreased neutrophil infiltration and adhesion molecules expression, accompanied by a remarkable increased protein kinase B phosphorylation in lung tissue. The mortality rate in apelin treated animals was also significantly reduced. Importantly, the above effects of apelin were abolished by LY294002 treatment.
CONCLUSION: Apelin regulates inflammatory response, diminishes inflammatory remote organ damage and improves survival in an experimental model of burn sepsis, which is at least partly mediated by a phosphatidylinositol 3-kinase/protein kinase B dependent pathway.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apelin; Burn; Inflammation; PI3K/Akt; Sepsis

Mesh:

Substances:

Year:  2015        PMID: 26163884     DOI: 10.1016/j.ijsu.2015.06.072

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  6 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

Review 2.  Vascular effects of apelin: Mechanisms and therapeutic potential.

Authors:  Amreen Mughal; Stephen T O'Rourke
Journal:  Pharmacol Ther       Date:  2018-05-25       Impact factor: 12.310

Review 3.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

4.  Fc-apelin fusion protein attenuates lipopolysaccharide-induced liver injury in mice.

Authors:  Huifen Zhou; Rongze Yang; Weimin Wang; Feng Xu; Yue Xi; Robert A Brown; Hong Zhang; Lin Shi; Dalong Zhu; Da-Wei Gong
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

5.  The apelinergic system as an alternative to catecholamines in low-output septic shock.

Authors:  David Coquerel; Xavier Sainsily; Lauralyne Dumont; Philippe Sarret; Éric Marsault; Mannix Auger-Messier; Olivier Lesur
Journal:  Crit Care       Date:  2018-01-19       Impact factor: 9.097

6.  Fc-Elabela fusion protein attenuates lipopolysaccharide-induced kidney injury in mice.

Authors:  Feng Xu; Huifen Zhou; Man Wu; Hong Zhang; Yixian Zhang; Qingbin Zhao; Robert Brown; Da-Wei Gong; Lining Miao
Journal:  Biosci Rep       Date:  2020-09-30       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.